Once your company receives an FDA alert — specifically an FDA import alert, sometimes called the FDA debarment list or FDA red list — your FDA imports can be FDA detained and held without physical examination (DWPE). This FDA detention triggers a customs FDA hold that blocks entry into the United States and creates serious financial and operational losses. We manage the full remediation process, aligned with FDA requirements, from the first FDA notice of action through final delisting.
Our regulatory team supports manufacturers, exporters, and importers through a structured remediation process built around FDA requirements — not guesswork.
We bring together FDA regulatory specialists, compliance analysts, and technical reviewers, so every stage of your case — from the initial FDA notice of action to the final Agency decision — is handled by people who work with these submissions every day.
Talk to a SpecialistAn FDA import alert authorizes U.S. Customs and Border Protection (CBP), acting under FDA direction, to detain products without physical examination when there is evidence suggesting non-compliance with FDA regulations. Companies often first learn about their status through an FDA notice of action, a customs FDA hold on a shipment, or by checking FDA import refusals and FDA advisories directly.
Removal requires demonstrating that the underlying issues have been fully corrected and that effective preventive measures are now in place.
We manage the complete regulatory process
We review the FDA basis for your listing, identify the specific violations cited in the FDA notice of action, and pinpoint the root cause behind the detention.
We work with your team to correct the underlying issues, update documentation, and put preventive controls in place that meet current FDA expectations.
We assemble the supporting evidence and help you build the record of compliant activity FDA looks for when evaluating a removal request.
We prepare and submit your formal removal petition, structured and documented to FDA's requirements.
We manage communication with FDA through the review, respond to Agency feedback, and carry the case through to a final decision — clearing your company from the FDA red list and preventing future FDA import refusals.
Our consultants have deep experience supporting international manufacturers through FDA compliance, FDA warnings, and FDA advisories. We deliver strategic, practical, documentation-driven solutions — while strengthening your long-term compliance program.
We handle correspondence with the Agency for you — timely, accurate, and on-record.
Every submission is built on the evidence FDA expects — not assertions.
One team carries your case from root-cause analysis through final delisting.
We don't just remove the alert — we help make sure it doesn't happen again.
FAQ
Once you're on an FDA import alert, future shipments can be held at the border automatically — a customs FDA hold without inspection — until you demonstrate compliance. Your goods stay in limbo while the underlying issue remains unresolved.
FDA import alerts reach every FDA-regulated category — food and beverages, dietary supplements, cosmetics, drugs, and medical devices. The specific violations cited differ by category, but the removal path follows FDA's established procedures.
It depends on the reason for the listing, how quickly corrective actions can be documented, and FDA's review. We move the parts we control as fast as possible; the final timeline rests with the Agency.
That the root cause has been fully corrected and that preventive measures are in place — supported by documentation and, where applicable, a record of compliant activity.
Yes. We manage correspondence with the Agency throughout the process, including any FDA notice of action or FDA warnings, so your responses are complete, timely, and properly documented.
© Distributed by